Essex Financial Services’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.54M Buy
21,384
+1,389
+7% +$107K 0.09% 203
2025
Q4
$1.59M Buy
19,995
+1,904
+11% +$150K 0.09% 201
2025
Q3
$1.36M Sell
18,091
-893
-5% -$61.2K 0.08% 211
2025
Q2
$1.31M Sell
18,984
-1,721
-8% -$113K 0.09% 205
2025
Q1
$1.4M Buy
20,705
+166
+0.8% +$9.93K 0.1% 181
2024
Q4
$922K Sell
20,539
-869
-4% -$48.8K 0.07% 248
2024
Q3
$1.22M Sell
21,408
-9,362
-30% -$546K 0.09% 200
2024
Q2
$1.78M Buy
30,770
+2,232
+8% +$140K 0.13% 150
2024
Q1
$2.28M Sell
28,538
-1,417
-5% -$108K 0.21% 102
2023
Q4
$2.37M Sell
29,955
-2,831
-9% -$201K 0.24% 91
2023
Q3
$2.29M Sell
32,786
-3,350
-9% -$237K 0.27% 81
2023
Q2
$2.5M Sell
36,136
-1,188
-3% -$84.5K 0.28% 75
2023
Q1
$2.77M Sell
37,324
-1,505
-4% -$126K 0.29% 86
2022
Q4
$3.62M Buy
38,829
+945
+2% +$91.2K 0.38% 66
2022
Q3
$3.61M Sell
37,884
-898
-2% -$88.9K 0.43% 53
2022
Q2
$3.59M Buy
38,782
+797
+2% +$77.8K 0.4% 60
2022
Q1
$3.85M Buy
37,985
+970
+3% +$102K 0.37% 68
2021
Q4
$3.82M Sell
37,015
-1,826
-5% -$169K 0.38% 64
2021
Q3
$3.3M Buy
38,841
+9,243
+31% +$774K 0.38% 61
2021
Q2
$2.23M Hold
29,598
0.32% 70
2021
Q1
$2.23M Sell
29,598
-2,949
-9% -$215K 0.4% 62
2020
Q4
$2.22M Buy
32,547
+128
+0.4% +$8.32K 0.44% 58
2020
Q3
$1.89M Buy
32,419
+2,002
+7% +$125K 0.46% 56
2020
Q2
$1.98M Sell
30,417
-1,768
-5% -$111K 0.61% 46
2020
Q1
$1.91M Sell
32,185
-1,370
-4% -$91.5K 0.68% 41
2019
Q4
$2.49M Buy
33,555
+2,557
+8% +$180K 0.69% 41
2019
Q3
$1.96M Sell
30,998
-1,057
-3% -$62.6K 0.63% 45
2019
Q2
$1.75M Sell
32,055
-883
-3% -$47.6K 0.52% 53
2019
Q1
$1.78M Sell
32,938
-2,024
-6% -$125K 0.54% 53
2018
Q4
$2.29M Buy
34,962
+9,179
+36% +$685K 0.7% 40
2018
Q3
$2.03M Buy
25,783
+3,667
+17% +$262K 0.45% 62
2018
Q2
$1.42M Buy
22,116
+4,937
+29% +$325K 0.34% 73
2018
Q1
$1.07M Sell
17,179
-1,170
-6% -$83.9K 0.21% 110
2017
Q4
$1.33M Sell
18,349
-1,917
-9% -$139K 0.32% 77
2017
Q3
$1.65M Sell
20,266
-412
-2% -$32.6K 0.4% 65
2017
Q2
$1.66M Sell
20,678
-5,004
-19% -$395K 0.35% 72
2017
Q1
$2.02M Sell
25,682
-1,703
-6% -$136K 0.46% 57
2016
Q4
$2.16M Sell
27,385
-5,008
-15% -$405K 0.46% 56
2016
Q3
$2.88M Sell
32,393
-2,499
-7% -$236K 0.69% 39
2016
Q2
$3.34M Sell
34,892
-1,102
-3% -$110K 0.81% 29
2016
Q1
$3.73M Sell
35,994
-1,144
-3% -$111K 0.92% 26
2015
Q4
$3.63M Sell
37,138
-282
-0.8% -$27.6K 0.87% 29
2015
Q3
$3.61M Buy
37,420
+3,729
+11% +$392K 0.94% 24
2015
Q2
$3.53M Buy
33,691
+572
+2% +$58.4K 0.91% 25
2015
Q1
$3.42M Sell
33,119
-890
-3% -$90.1K 0.88% 25
2014
Q4
$3.27M Buy
34,009
+8,141
+31% +$717K 0.85% 31
2014
Q3
$2.06M Buy
25,868
+6,187
+31% +$488K 0.62% 37
2014
Q2
$1.48M Buy
19,681
+332
+2% +$25.1K 0.44% 54
2014
Q1
$1.45M Buy
19,349
+464
+2% +$32.8K 0.47% 52
2013
Q4
$1.35M Buy
18,885
+1,991
+12% +$128K 0.46% 51
2013
Q3
$959 Sell
16,894
-1,328
-7% -$79.1K 0.3% 73
2013
Q2
$1.04M Buy
+18,222
New +$1.06M 0.36% 61

Other funds holding CVS

Essex Financial Services's CVS Position: Q1 2026 in Review

Essex Financial Services increased its CVS Health (CVS) stake by 6.9% in Q1 2026, buying an estimated $107K and bringing the position to 21,384 shares worth $1.54M. The position accounts for 0.09% of the portfolio, ranked #203.

Essex Financial Services first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.85M in Q1 2022. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Essex Financial Services held 21,384 shares of CVS Health worth $1.54M as of Q1 2026.
  • Essex Financial Services bought 1,389 CVS Health shares in Q1 2026, an estimated $107K.
  • CVS Health made up 0.09% of Essex Financial Services's portfolio in Q1 2026, its #203 holding.
  • Essex Financial Services first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Essex Financial Services's CVS Health position peaked at $3.85M in Q1 2022.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Essex Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.